Home › Articles › Volume 8, Issue 1 › Outcome Analysis of Cisplatin-5 Flurouracil and Week...
Moradabad, India
Original Article
Oncology

Outcome Analysis of Cisplatin-5 Flurouracil and Weekly 5-Flurouracil in Advanced Gastric Cancer.


Volume 8, Issue 1, Pages 1-4

Authors

G. Raja1, K. Kalaichelvi1
Affiliation:
1Madras Medical College, Chennai, Tamil Nadu, India.

Corresponding Author

G. Raja

Abstract

Background: Advanced gastric cancer patients has poor survival rate of < 20% at 5 years. We intended to evaluate the outcomes of Cisplatin and 5-Flurouracil combination chemotherapy or 5 FU alone in this setting. Objectives: In this study we analyzed the outcomes such as response rate, progression free survival (PFS) at 6 months, and toxicity profiles of 3 weekly Cisplatin and 5-Flurouracil (PF) regimen and Weekly 5-Flurouracil (5-FU) therapy in advanced gastric cancer. Subjects and Methods: The outcomes of the chemotherapeutic regimens such as intravenous infusion of Cisplatin 75mg/m2 in divided doses and 5-Flurouracil 750mg/m2 for consecutive 3 days every 21 days (Group A) and intravenous infusion of 5-Flurouracil 500mg flat dose every week for 16 weeks (Group B) in stage III/IV gastric cancer were analyzed. Baseline parameters were obtained. Results: Twenty patients for both PF and weekly 5-FU regimens were recruited. The Overall response rate of Group A and B regimen was 40% and 20% respectively. PFS at the end 6 months was 60% and 35% respectively. Median time to progression was 5 months in group A and 3.6 months in group B. Hematological toxicity and Non hematological toxicity rates were in the acceptable range in Group A. Conclusion: Three weekly Cisplatin and 5-Flurouracil could be a good regimen when the performance status of the patient is good. Weekly 5-Flurouracil gives good quality of life and this regimen can be considered when the patient is not eligible for Cisplatin and 5-Flurouracil regimen in advanced gastric cancers.

Keywords

Stomach neoplasm, Cisplatin, Fluorouracil, Progression free survival.

History

Received 01 February 2019

Accepted 01 March 2019

DOI

10.21276/ajmr.2019.8.1.MC1

Author Notes

Corresponding Author: Dr. G. Raja, Madras Medical College, Chennai, Tamil Nadu, India.

Open Access

It is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits authors to retain ownership of the copyright for their content, and allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited. https://creativecommons.org/licenses/by/4.0/

Copyright

Copyright: © the author(s), 2019.

Cite this Article

Formats

                                                
Actions
Download PDF
Metrics
10
Downloads
8
Views
Journal
Journal Asian Journal of Medical Research
Volume Volume 8
Issue Issue 1
Year 2019

Purchase access plans

Select the plan that best fits your need

Loading plans...

Statistics:

Views: 0
Downloads: 0

Asian Journal of Medical Research (AJMR) is an international, peer-reviewed, quarterly open-access journal publishing advanced research across medical specialties.

Quick Links

For Authors

© 2026 Asian Journal of Medical Research. All Rights Reserved.Designed and Developed By Kryoni